Prognostic and Predictive Effect of TP53 Mutations in Patients with Non-Small Cell Lung Cancer from Adjuvant Cisplatin-Based Therapy Randomized Trials: A LACE-Bio Pooled Analysis.
- Citation:
- J Thorac Oncol vol 11 (6) 850-61
- Year:
- 2016
- Type:
- Manuscript
- Funding:
- Not Funded
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Meta-Analysis
- Data Sharing:
- Alliance-data-source,-external-user
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- http://www.ncbi.nlm.nih.gov/pubmed/26899019
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- U10CA180821
- Corr. Author:
- Authors:
- Xiaoli Ma Gwénaël Le Teuff Benjamin Lacas Ming Sound Tsao Stephen Graziano Jean-Pierre Pignon Jean-Yves Douillard Thierry Le Chevalier Lesley Seymour Martin Filipits Robert Pirker Pasi A Jänne Frances A Shepherd Elisabeth Brambilla Jean-Charles Soria Pierre Hainaut
- Networks:
- 11030, LAPS-MA036, NY141
- Study
- CALGB-150802
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-9633
- Phases:
- N/A, 3
- Keywords:
- Lung cancer, Predictive, Prognostic, TP53 mutations